At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of Transdermal and Oral Estrogens in Adolescents With Ovarian Failure
In Brief
A clinical study evaluating 17beta Estradiol, Conjugated estrogens, and 2 other interventions for Ovarian Failure, Premature. Completed, enrolled 20 participants across 1 site.
Detailed Summary
To directly compare the safety (by laboratory evaluation) and efficacy (feminization and growth) of three commonly used estrogen preparations in adolescent patients with ovarian failure, either due to congenital causes (Turner syndrome) or medical therapies. We hypothesize that transdermal estrogen will have equivalent efficacy and a more favorable safety profile in comparison with conventional oral estrogen replacement.
Study Details
Timeline
Interventions
Oral pill given daily at increasing doses every 6 months for 18 months.
Oral pill, started at a low dose taken daily, dose increased every 6 months for 18 months
Transdermal estrogen patch, started at low dose with increasing doses eery 6 months for 18 months
Given starting at 18 months